Wall Street Zen Downgrades Aterian (NASDAQ:ATER) to Sell

Aterian (NASDAQ:ATER) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday.

Separately, Weiss Ratings raised Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, May 19th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Aterian presently has a consensus rating of “Sell”.

Aterian Stock Performance

NASDAQ ATER opened at $0.40 on Friday. The stock has a 50-day simple moving average of $1.18 and a 200 day simple moving average of $0.88. The company has a market capitalization of $4.36 million, a PE ratio of -0.16 and a beta of 0.68. Aterian has a 12 month low of $0.40 and a 12 month high of $1.87.

Aterian (NASDAQ:ATER) last released its earnings results on Friday, May 15th. The company reported ($0.39) earnings per share for the quarter, beating the consensus estimate of ($0.69) by $0.30. Aterian had a negative return on equity of 82.05% and a negative net margin of 39.56%.The firm had revenue of $0.02 million for the quarter, compared to analyst estimates of $15.82 million.

Hedge Funds Weigh In On Aterian

Institutional investors and hedge funds have recently made changes to their positions in the company. Susquehanna International Group LLP increased its position in shares of Aterian by 310.2% in the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after buying an additional 30,637 shares in the last quarter. Citadel Advisors LLC lifted its holdings in Aterian by 222.0% during the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after acquiring an additional 22,865 shares in the last quarter. XTX Topco Ltd bought a new position in Aterian during the second quarter worth about $55,000. Finally, Goldman Sachs Group Inc. grew its stake in Aterian by 73.0% in the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after acquiring an additional 9,026 shares during the period. Institutional investors and hedge funds own 7.02% of the company’s stock.

Aterian Company Profile

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.